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ABSTRACT
To determine whether it was feasible to perform a randomized controlled trial (RCT) comparing arthroscopic
hip surgery to conservative care in patients with femoroacetabular impingement (FAI). This study had two
phases: a pre-pilot and pilot RCT. In the pre-pilot, we conducted interviews with clinicians who treated FAI and
with FAI patients to determine their views about an RCT. We developed protocols for operative and conservative
care. In the pilot RCT, we determined the rates of patient eligibility, recruitment and retention, to investigate the
feasibility of the protocol and we established methods to assess treatment ﬁdelity. In the pre-pilot phase, 32 clin-
icians were interviewed, of which 26 reported theoretical equipoise, but in example scenarios 7 failed to show clin-
ical equipoise. Eighteen patients treated for FAI were also interviewed, the majority of whom felt that surgery and
conservative care were acceptable treatments. Surgery was viewed by patients as a ‘deﬁnitive solution’. Patients
were motivated to participate in research but were uncomfortable about randomization. Randomization was more
acceptable if the alternative was available at the end of the trial. In the pilot phase, 151 patients were assessed for
eligibility. Sixty were eligible and invited to take part in the pilot RCT; 42 consented to randomization. Follow-up
was 100% at 12 months. Assessments of treatment ﬁdelity were satisfactory. An RCT to compare arthroscopic
hip surgery with conservative care in patients with FAI is challenging but feasible. Recruitment has started for a
full RCT.
INTRODUCTION
Arthroscopic hip surgery for femoroacetabular impinge-
ment (FAI) is a rapidly growing and evolving field with
increasing number of patients undergoing surgical
treatment [1, 2]. In case series, 80% of patients report
improvement at 2 years after either surgery or a conserva-
tive care programme that includes physiotherapist-led
treatments such as education and exercise [3, 4]. A recent
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Cochrane review highlighted the lack of evidence from
randomised trials to assess the relative clinical and cost ef-
fectiveness of these two strategies [5]. There has been en-
thusiasm in the surgical community in several countries
and among commissioners of healthcare for such a trial in
the management of FAI [6].
However, conducting RCTs is challenging; clinician and
patient equipoise, and the ability to recruit adequate num-
bers of patients are major obstacles to trials, especially in
surgery [7–9]. This is made even more difficult if the com-
parator arm is conservative care [10, 11].
There was uncertainty as to whether surgeons or patients
would be prepared to take part in an RCT comparing sur-
gery with conservative care for FAI. We performed a feasibil-
ity study, including an internal pilot trial, to understanding
clinician and patient equipoise, and to assess trial proced-
ures, eligibility criteria, recruitment and retention rates in
order to determine whether to proceed to a full trial.
METHODS
We conducted this mixed methods feasibility study in two
phases: a pre-pilot qualitative research phase that aimed to
explore surgeon and patient equipoise followed by a mixed
methods internal pilot RCT that aimed to test out the
planned trial procedures including eligibility assessment,
participant recruitment and retention rates, as well as de-
velop a method of assessing intervention fidelity. Ethical
approval was obtained from the NHS Research Ethics
Committee (11/WM/0389). A detailed report of this
study is available in a Health Technology Assessment (HTA)
Journal monograph [12].
Phase 1: Pre-pilot Phase
Clinician interviews
Semi-structured interviews were conducted with a conveni-
ence sample of clinicians with a specialist interest in treat-
ing hip pain including orthopaedic surgeons, sports
physicians and physiotherapists, to explore the level of
equipoise within the community about an RCT comparing
surgery with conservative care. Clinicians were presented
with a series of cases covering a spectrum of presentations
of FAI and asked to ‘think aloud’ when considering the
cases, with prompting questions used, to deconstruct the
cognitive process when considering whether to recruit a
patient into an RCT. Clinician interviews were recorded
and analysed thematically [13].
Patient interviews
A panel of expert patients was established from patients
who had been treated for FAI by D.G. The panel was
selected by purposive sampling to be representative of a
broad range of ages, pathology, socioeconomic class, activ-
ity levels and gender. The sample-included patients treated
through surgery and conservative care. Invitations were
sent to patients inviting them to participate in semi-
structured, one-to-one interviews and to review proposed
trial patient information sheets.
Interviews were audio recorded and fully transcribed.
Transcriptions were thematically analysed to extract key
messages about patients’ experiences and the acceptability
of proposed trial treatments and of randomization.
Phase 2: Pilot RCT
A pragmatic, multicentre, two-parallel arm pilot RCT of
arthroscopic hip surgery versus best conservative care for
FAI was undertaken at 10 NHS centres across the UK to
determine eligibility, recruitment and retention rates and
to test trial procedures. The trial was designed as an in-
ternal pilot RCT such that, should the findings show that a
full trial was feasible, the main trial could follow without
significant delay [14]. The trial was overseen by a trial
management group and independent trial steering and
data monitoring committees.
Participants
Eligible patients were identified from among those present-
ing to young adult hip clinics in 10 NHS centres.
The following eligibility criteria for a RCT were agreed:
Subjects were included if they:
i. Were aged 16 years.
ii. Had symptoms of hip pain—they may also have
had symptoms of clicking, catching or giving way.
iii. Showed radiographic evidence of pincer- or cam-
type FAI on plain radiographs and cross-
sectional imaging [15].
iv. The treating surgeon believed that they would
beneﬁt from arthroscopic FAI surgery.
v. Were able to give written informed consent and
to participate fully in the interventions.
Patients were excluded if there was:
1. Previous signiﬁcant hip pathology such as
Perthes’ disease, slipped upper femoral epiphysis
or avascular necrosis.
2. Previous hip injury such as acetabular fracture,
hip dislocation and femoral neck fracture.
3. Osteoarthritis, deﬁned as To¨nnis grade>1, or
more than 2-mm loss of superior joint space
width on AP pelvic radiograph [4, 16].
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4. Evidence that the patient would be unable to par-
ticipate fully in the interventions, adhere to trial
procedures or complete questionnaires, such as
cognitive impairment or intravenous drug abuse.
5. Previous shape changing surgery (open or arthro-
scopic) in the hip being considered for treatment.
Participating surgeons identified eligible patients in their
routine hip clinics, and invited them to a trial information
consultation with a trained research nurse. During this con-
sultation, information was provided about FAI including
an information sheet (see Supplementary data, Appendix
S1), using methods described by Realpe et al. [17].
Patients who provided written informed consent were
randomized in a 1:1 ratio, using a computer generated tele-
phone randomization service minimized by study centre,
to receive arthroscopic surgery or best conservative care.
Interventions
Arthroscopic surgery. The arthroscopic surgery within the
trial was delivered by NHS orthopaedic consultant special-
ising in hip surgery and included:
• Pre-operatively, routine pre-operative assessment.
• Peri-operatively, patients underwent arthroscopic hip
surgery under general anaesthesia. Shape abnormalities
and consequent pathology were addressed. Adequacy of
bony resection was assessed by intra-operative image in-
tensiﬁer radiographs and/or satisfactory impingement
free range of movement of the hip.
• Post-operatively, patients were discharged when they
were ambulatory and safe with or without the aid of
crutches. On discharge all patients were referred to
outpatient-led physiotherapy services for the surgeons
usual course of rehabilitation.
Best conservative care. During the feasibility study a protocol
for best conservative care called ‘Personalised Hip
Therapy’ (PHT) was developed through the Delphi
method, nominal group technique and a consensus devel-
opment conference [18–22]. Participants received the
PHT protocol from an NHS physiotherapist specialising in
musculoskeletal care who had attended a PHT workshop.
The agreed protocol consisted of:
• Pre-treatment—patients received an information leaﬂet
that provided details about PHT.
• Treatment consisted of:
• A detailed assessment
• Patient education
• Help with pain relief
• An exercise programme that was individualised,
supervised in clinic and practiced at home and pro-
gressed over time
• A minimum of 6 treatment contacts over at least
12 weeks.
After the 12-week treatment period, participants could
be offered additional support or guidance in up to four
contacts with the physiotherapist. Details of the develop-
ment, and protocol for delivery, of PHT have been pub-
lished elsewhere [12].
Outcomes
The aim of the pilot RCT was to assess eligibility, recruit-
ment and retention rates and test study procedures includ-
ing assessment of fidelity. Participants were followed up to
test the protocol for a full RCT. Outcomes were collected
by researchers blinded to the treatment allocation at base-
line (before randomisation), and at 3, 6 and 12 months
after randomisation, using postal questionnaires and, when
participants failed to respond, phone calls and emails. The
following patient-reported outcomes were collected:
• Hip related quality of life measured by the International
Hip Outcome tool 33 (iHOT33) [23].
• Hip pain and function measured by the Non Arthritis
Hip Score (NAHS) [24].
• Activity level measured by the University of California
Los Angeles (UCLA) activity score (baseline only)
[25].
• General health by the Short Form 12 (SF12) [26].
• Health related quality of life by the EQ5D 5 L [27].
• Adverse events (AE). At 6 weeks after treatment a com-
plication log was collected by telephone. We recorded
number and type of AE up to 12 months.
• Resource utilisation Information on health care resource
use was collected [28].
Treatment fidelity
The quality of the evidence produced by a full RCT de-
pends on the fidelity with which the two treatments being
compared are implemented. The following measures to de-
termine treatment fidelity were developed and tested in
the pilot RCT.
Arthroscopic hip surgery. For each participant, a vignette
was prepared comprising; an operation note, two intra-op-
erative photos and six reconstructed images from a post-
operative three-dimensional (3D) single sequence mag-
netic resonance volume acquisition scan—see
Supplementary data, Appendix S2.
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Each vignette was then analysed by an international ex-
pert group comprising of M.P. (surgeon, USA), M.B. (sur-
geon, Switzerland), J.O. (surgeon, Australia) and C.H.
(radiologist, UK), for adherence to the treatment protocol
by assessing whether satisfactory surgery had been under-
taken. Disagreements were resolved by discussion and
group consensus.
Best conservative care: personalised hip therapy. For each trial
participant, physiotherapists recorded full details of the ad-
vice and treatments, number and mode of treatment con-
tacts, any non-attendance and any AE on specifically
designed case report forms (CRFs)—see Supplementary
data, Appendix S3. Following discharge from physiother-
apy care, patients’ CRFs were assessed by the panel of ex-
perts who developed the PHT protocol (I.H. and D.R.;
senior physiotherapists with interest in FAI, N.F.; academic
musculoskeletal physiotherapist, P.W.; academic ortho-
paedic surgeon), to judge whether PHT was delivered per
protocol. Disagreements were resolved by discussion and
group consensus.
Sample size
The pilot RCT was not powered to estimate a between-
group treatment effect, but rather to achieve a reasonable
confidence interval around the estimate of the proportion
of eligible patients who consent to participate. Previous
studies in orthopaedic surgery of operative compared with
non-operative treatments have achieved recruitment rates
of 30%, so we modeled around this. Approaching 60 pa-
tients to invite them to take part in the trial would allow a
95% CI of 18–41% if the true recruitment rate was 30%.
We judged this to be a good balance between cost and dur-
ation of the pilot RCT and the required precision of the es-
timate.
RESULTS
Phase 1: Pre-Pilot Phase
Clinician interviews
Twenty-eight clinicians agreed to be interviewed, including
14 hip surgeons, 12 physiotherapists and two sports phys-
icians who attended an arthroscopic hip surgery conference
(Sports Hip, Warwick 2012).
Equipoise in theoretical terms was stated by 26 (90%)
clinicians. However, five surgeons and two physiotherapists
did not express equipoise when presented with case scen-
arios of patients eligible for the RCT.
One surgeon fundamentally did not believe in FAI and
felt it was over diagnosed and a trial lacked relevance. Two
surgeons reported preferring a conservative treatment. The
remaining two surgeons and two physiotherapists felt sur-
gery was the optimal treatment.
Seven surgeons demonstrated active theoretical and
clinical equipoise and were invited to participate in the
pilot RCT.
When discussing the planned RCT, 10 surgeons were
concerned about the duration of such a trial. They felt
there was a need to balance length of follow-up, to measure
the difference between treatments, with the potential for
the deterioration with continuing with one treatment
and failing to improve. They felt 12 months was acceptable
allowing patients’ symptoms to stabilise after
treatment. The majority of clinicians thought patients
would prefer surgery and might respond negatively to
randomisation.
The physiotherapists and sports physicians frequently
mentioned need for clarity on eligibility criteria for a trial
and the need for a unique conservative care since they felt
that many FAI patients would report having tried a course
of conservative care prior to their consultation with the
surgeon. Full transcripts of the clinician interviews are pub-
lished elsewhere [12].
Patient interviews
Eighteen patients were involved in the expert patient panel
(surgery n¼ 14 conservative care n¼ 4); the majority was
young and physically active. They reported that FAI had
limited their everyday and recreational activities, and that it
was this that led them to seek treatment.
The expert patients agreed that both treatments were
acceptable. Many found that having a conservative care op-
tion was positive. However, the majority felt that surgery
was a ‘solution’ to a condition caused by ‘abnormal bone’.
Patients felt that conservative treatment was attractive as it
was less invasive.
Patients were motivated to participate in research to
help clinicians improve their knowledge but also to help fu-
ture patients. The panel presumed that surgeons would
know what was best for them and felt uncomfortable being
randomised to receive a treatment as they perceived that
the surgeon would not be looking after their best interest.
The process of randomisation was more acceptable if the
alternative treatment was available at the end of the trial
should the patient still be symptomatic.
The patients’ felt that it was important that their treat-
ment plan met their individual needs and the clinical team
should continue to provide care during and after the trial,
whichever arm they were allocated to. Full transcripts of
the patient interviews are published elsewhere [12].
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Phase 2: Pilot RCT
Recruitment
Details of the eligibility and recruitment of patients is dis-
played in Fig. 1. Trial set-up was delayed in one centre and
it therefore did not participate in recruitment of the first
60 subjects. Sixty patients fulfilled the eligibility criteria
and were approached. Forty-two patients (70%; 95% CI
58–81%) consented to participate in the trial. Eighteen pa-
tients declined to participate; 11 preferred surgery and 3
preferred PHT.
The baseline characteristics for the trial participants in
each treatment arm are shown in Table I. Patients demo-
graphics were as expected; being young and active (50%
had UCLA score of 1, 2 or 3 indicating regular participa-
tion in sport).
Follow up
Thirty-eight participants (91%) received the treatment to
which they were randomised; one patient did not receive
surgery within 12 months, two patients declined their
treatment (PHT n¼ 1, surgery n¼ 1) and one patient
crossed over from PHT to surgery before their 3 month
follow-up. Follow-up rates were 93, 91 and 100% at 3, 6
and 12 months, respectively. There were no serious AE
reported.
Treatment fidelity
Arthroscopic hip surgery. The first surgery review panel as-
sessed seven patients who underwent surgery. The panel
felt that the quantity and quality of the information pre-
sented was sufficient to make a decision on the adequacy
of the surgery. Each operation was rated as either per
protocol, borderline or not demonstrating protocol care.
The panel rated six operations as per protocol care. One
procedure was rated as not demonstrating per protocol
care; in this case the surgeon did not proceed with shape
changing surgery due to a large area of cartilage loss. The
panel felt that although not per protocol care this was clin-
ically appropriate.
Best conservative care—personalised hip therapy. The first
PHT fidelity panel assessed PHT CRFs and the physio-
therapy notes for the first eight patients to undergo treat-
ment. The panel found that the CRF accurately reflected
the physiotherapy notes and that the CRF could be used
to judge treatment fidelity for future cases. Five of the eight
cases reviewed were judged to be in line with the protocol.
Protocol deviations were due to inadequate number of
treatment contacts (n¼ 2) and no CRF completed
(n¼ 1).
DISCUSSION
We have the feasibility of a pragmatic, multicentre RCT to
compare the clinical and cost-effectiveness of arthroscopic
hip surgery with best conservative care in patients with
FAI. Clinicians are in sufficient equipoise and are willing to
invite their patients to join an RCT. Our patient panel
interviews demonstrated that patients are equally willing to
participate in research although they want treatment to be
individualised and are cautious about randomization.
Having designed a package of best conservative care
(PHT), we prospectively assessed patients’ willingness to
participate in a pilot RCT. We found that 70% of eligible
patients agreed to participate in an RCT.
The pre-pilot qualitative research offered an opportunity
to detect key areas of concern for potential participants and
respond to these challenges. Our expert patient panel ex-
pressed a reluctance to be randomised in a research trial;
however, this retrospective view of patients already success-
fully treated was not apparent during the pilot RCT where
70% of eligible patients agreed to be randomised. We believe
that this reflects the care that the research nurses, trained by
the trial team, took to explain the trial in detail to eligible pa-
tients, and to the way in which the process of randomisation
was presented to patients without negative connotations.
By designing a specific conservative care treatment,
PHT, through consensus methodology, we were able to al-
leviate the fears of our clinician and patient panels that
conservative treatment would need be ‘unique’ and
‘individualised’. Clinicians also thought that patients would
prefer surgery. However only 30% eligible declined to par-
ticipate; of those, 11 (61%) had a preference for surgery.
When testing trial protocols, only one PHT patient crossed
over to surgery during the 1-year follow up.
A strength of the study was that it took in the opinions
of a broad group of clinicians treating FAI as well as pa-
tients with experience of surgery and conservative care.
Strengths of the pilot RCT were that it was multicentre
and pragmatic. A key strength was the design of the pilot
RCT as an internal pilot trial, such that progression to the
full trial could proceed without significant delay and that
the 42 patients randomised in the pilot could be included
in a full trial. It is for this reason that we cannot report the
outcomes of the patients recruited in the pilot study.
Following this study, funding was received from the
Health Technology Assessment programme (13/103/02)
to progress to a full RCT (ISRCTN64081839). This trial
is called FASHIoN: a Full randomised controlled trial of
Arthroscopy Surgery for Hip Impingement versus best
coNventional care. The full trial aims to recruit 344 pa-
tients (making this the largest RCT of FAI treatment
planned worldwide) in 25 centres, and we anticipate
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reporting results in mid-2017. We have collaborated with
colleagues in Australia to use the same protocol for a simi-
lar trial in five centres (ACTRN 12615001177549).
CONCLUSION
This feasibility and pilot study shows that it is feasible to
conduct a full RCT comparing arthroscopic surgery to con-
servative care in patients with FAI. Supported by this
evidence, the UK National Institute for Health Research
HTA programme has now commissioned a full trial, which
is underway.
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Fig. 1. CONSORT diagram.
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